Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix, Life Tech to Develop MDx Platform for Food Safety Testing

NEW YORK (GenomeWeb News) – Molecular diagnostics company Rheonix today announced a joint development agreement with Life Technologies aimed at a molecular testing platform for the applied markets.

Rheonix will supply its technology developed for the molecular diagnostics market, including its CARD disposable cartridges, to Life Tech for marketing, sales and distribution. Together the two companies will develop a platform designed for the food safety testing market that will enable laboratories to detect disease-causing organisms, including serotype identification in a fully automated format. The platform is targeted for a market launch next year.

The CARD system is a microfluidic platform that fully automates all the functions of a molecular biology lab on a small disposable chip.

Along with addressing the applied market, the deal, Ithaca, NY-based Rheonix said, will "significantly" shorten the time by which it can enter the clinical market it its sample-to-result molecular diagnostic instrument.

Financial and other terms were not disclosed.

On Monday Life Tech also announced a five-year food safety deal with the US Food and Drug Administration aimed at detecting E. coli and Salmonella.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.